A Study of LY4088044 in Healthy Participants
Phase 1
104
about 2 years
18–65
4 sites in CA, KS, TX +1
What this study is about
This trial is testing a new drug called LY4088044 to see how well it's tolerated and what side effects might occur. The drug will be given either under the skin or into a vein, and blood tests will monitor its levels and elimination from the body. It lasts up to 92 weeks.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take LY4088044
- 2.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Number of Participants with One or More Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to Study Drug Administration
Secondary: PK: Area Under the Concentration Versus Time Curve (AUC) of LY4088044, Pharmacodynamics (PD): Protein Levels in Skin Samples, Pharmacokinetics (PK): Maximum Concentration (Cmax) of LY4088044